ADA and rheumatoid arthritis: The aim of our study was to assess the relationship between clinical response, adverse events, and TNFα blockers serum levels and antidrug Ab concentrations in RA and SpA (AS and psoriatic arthritis (PsA)) patients treated with ADA, ETA, and INF for a long period of time.